HM
MDGL icon

HealthCor Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

HealthCor Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-902,601
Closed -$100M – 95
2020
Q4 		$100M Sell
902,601
-227,347
-20% -$27.8M 3.87% 6
2020
Q3 		$134M Sell
1,129,948
-67,936
-6% -$7.38M 5.37% 5
2020
Q2 		$136M Sell
1,197,884
-204,366
-15% -$20.1M 5.68% 3
2020
Q1 		$93.6M Buy
1,402,250
+313,940
+29% +$26.2M 4% 9
2019
Q4 		$99.2M Buy
1,088,310
+57,090
+6% +$5.54M 3.54% 8
2019
Q3 		$88.9M Sell
1,031,220
-1,050
-0.1% -$98.5K 3.36% 10
2019
Q2 		$108M Buy
1,032,270
+140,280
+16% +$15M 4.2% 5
2019
Q1 		$112M Buy
891,990
+203,100
+29% +$25.2M 4.51% 7
2018
Q4 		$77.7M Buy
688,890
+426,030
+162% +$65.9M 2.43% 17
2018
Q3 		$56.3M Buy
262,860
+65,579
+33% +$16.5M 1.87% 23
2018
Q2 		$55.2M Buy
+197,281
New +$34.6M 1.75% 23

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

HealthCor Management's MDGL Position: Q1 2021 in Review

HealthCor Management sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2021, closing a stake of 902,601 shares — an estimated $100M sold.

HealthCor Management first reported a position in MDGL in Q2 2018 and held it in 11 quarters. The position peaked at $136M in Q2 2020. 137 funds tracked by Wall St. Rank hold MDGL as of Q1 2021.

  • HealthCor Management reported no remaining Madrigal Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • HealthCor Management sold 902,601 Madrigal Pharmaceuticals shares in Q1 2021, an estimated $100M.
  • HealthCor Management first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 11 quarters.
  • HealthCor Management's Madrigal Pharmaceuticals position peaked at $136M in Q2 2020.
  • 137 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2021.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.